<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_SDU-CHINA_Model skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:SDU-CHINA/Model</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV class="body"><DIV id="header"><DIV id="menu"><UL><LI><A href="#">PROJECT ▾</A></LI><LI><A href="https://2018.igem.org/Team:SDU-CHINA/Description">Description</A></LI><LI><A href="https://2018.igem.org/Team:SDU-CHINA/Design">Design</A></LI><LI><A href="https://2018.igem.org/Team:SDU-CHINA/Results">Results</A></LI><LI><A href="https://2018.igem.org/Team:SDU-CHINA/Demonstrate">Demonstrate</A></LI></UL><LI><A href="#">WETLAB ▾</A></LI><LI><A href="https://2018.igem.org/Team:SDU-CHINA/Experiments">Protocols</A></LI><LI><A href="https://2018.igem.org/Team:SDU-CHINA/Notebook">Notebook</A></LI><LI><A href="https://2018.igem.org/Team:SDU-CHINA/Safety">Safety</A></LI><LI><A href="#">DRYLAB ▾</A></LI><LI><A href="https://2018.igem.org/Team:SDU-CHINA/Model">Model</A></LI><LI><A href="https://2018.igem.org/Team:SDU-CHINA/Hardware">Hardware</A></LI><LI><A href="#">TEAM ▾</A></LI><LI><A href="https://2018.igem.org/Team:SDU-CHINA/Team">Members</A></LI><LI><A href="https://2018.igem.org/Team:SDU-CHINA/Attributions">Attributoins</A></LI><LI><A href="https://2018.igem.org/Team:SDU-CHINA/Collaborations">Collaborations</A></LI><LI><A href="https://2018.igem.org/Team:SDU-CHINA/InterLab">INTERLAB</A></LI><LI><A href="#">PARTS ▾</A></LI><LI><A href="https://2018.igem.org/Team:SDU-CHINA/Parts">Parts</A></LI><LI><A href="https://2018.igem.org/Team:SDU-CHINA/Improve">Improve</A></LI><LI><A href="https://2018.igem.org/Team:SDU-CHINA/Human_Practices">HUMAN PRACTICES ▾</A></LI><LI><A href="https://2018.igem.org/Team:SDU-CHINA/Human_Practices#Silver">Silver</A></LI><LI><A href="https://2018.igem.org/Team:SDU-CHINA/Human_Practices#integrated">Gold &amp; Integrated</A></LI><LI><A href="https://2018.igem.org/Team:SDU-CHINA/Public_Engagement">Engagement</A></LI></DIV></DIV><DIV class="conteudo"><DIV class="paragraphs"><H1 id="main-title">Model</H1><H4 id="main-title">What is flux balance analysis (FBA)</H4><P>Flux balance analysis (FBA) is a mathematical model which attempts to simulate metabolic distributions of a cell. Different from ODE, FBA does not need kinetic parameters, as well as the initial concentration of each metabolites. Therefore, simulations using FBA are computationally inexpessive and can process a large number of metabolic fluxes in a few seconds on a PC<SUP>[1]</SUP>.</P><P>In the model, metabolic reactions are represented as a stoichiometric matrix. Negative coefficients are used to represent metabolites consumed, positive coefficients are used to represent metabolites produced, and the zero is used to represent those metabolites does not participate in a particular reaction.<SUP>[2]</SUP> Then a stoichiometric matrix that represents metabolic reacions can be constructed with these coefficients.</P><P>$$\frac{dX}{dt}=Sv\text{     (1)}$$</P><P>where X is the concentration of metabolites, S is a stoichiometric matrix, and v is the metabolic reaction. Since FBA calculates the change in concentration of metabolites at steady state, thera is</P><P>$$\frac{dX}{dt}=0\text{     (2)}$$</P><P>FBA seeks to maximize or minimize an objective function Z, which can be any linear combination of fluxes under the constraint conditions (1) and (2), as below</P><P>$$Z=c^Tv\text{     (3)}$$</P><P>where c is a vector of weights indicating how much each reaction contributes to the objective function.</P><P>FBA uses linear programming to solve it. We choose a powerful toolbox called COBRApy to implement FBA<SUP>[3]</SUP>. As a result, it is expected that the predicted metabolic flux distributions will explain many phenomenon in our project and then guide us to complete the project.</P><H4 id="main-title">Using FBA in our project</H4><H4>Feasibility Analysis</H4><P>In principle, the more the amount of crRNA is, the higher the inhibitory rate against <I>gltA</I> is. Supposing that the decrease of the flux of citrate synthesis is proportional to the inhibitory rate against <I>gltA</I>, we model the flux of BIOMASS and the two competitive flux (CS and ACACT1r) with the increase of it. Our predictive result is as follow.</P><DIV style="text-align: center; font-size: 15px">Figure 1. Feasibility Analysis.</DIV><P>As expected, with the increase of the inhibitory rate, the growth rate characterized by BIOMASS decreases, and the objective flux ACACT1r increases. It suggests that the suppression of <I>gltA</I> would redirect part of CS flux to the objective pathway and would inhibit the growth of <I>E. coli</I>.</P><H4>Flux Distributions in Different Culture Medium</H4><P>Our experiments show that crRNA inhibits the growth of <I>E. coli</I> at different extent in different culture medium.  To explain the phenomenon, We model the metabolic flux distributions in different culture medium.</P><P>In our model, We can see that <I>E. coli</I> using glucose as sole carbon source has higher threshold of crRNA's inhibiting growth significantly than <I>E. coli</I> using glycerol as sole carbon source. It causes that <I>E. coli</I> using glycerol as sole carbon is easier to be inhibited by crRNA than that using glucose as sole carbon, which is matched by our experiment results.</P><DIV style="text-align: center; font-size: 15px">Figure 2. <I>E. coli</I> using glucose as sole carbon source and <I>E. coli</I> using glycerol as sole carbon source.</DIV><P>The figure above shows the effects of adding yeast extraction to the media which uses glycerol as sole carbon. Compared with the predictive result of no addition of yeast extraction, it can be seen that the addition of yeast extraction eliminates the influences of crRNA to the growth rate, which is also matched by our experiment results.</P><DIV style="text-align: center; font-size: 15px">Figure 3. The effects of adding yeast extraction to the media which uses glycerol as sole carbon.</DIV><P>Furthermore, in terms of adding the yeast extraction, supposing that the inhibitory rate of <I>gltA</I> is 80%, we analyze the flux distribution center on the acytel-CoA, which distributes part of flux to CS and ACACT1r. As we can see, even though the ratio of the objective flux - ACACT1r increases from 7% to 18%, the flux responsible for producing its precursor - acytel-CoA decreases from 51.18 to 18.60, causing the total flux of the objective flux essentially unchanged.</P><DIV style="text-align: center; font-size: 15px">Figure 4. Flux distribution analysis (FBA) of <I>E. coli</I> growing in the media added glycerol and yeast extraction.</DIV><H4 id="main-title">How to Optimize Our Project In the Future</H4><P>According our human practice, we know that the medium component is very important to industrial production. To optimize our project in the future, we examine a variety of additional nutrient by production potential analysis.</P><H4>Carbon sources analysis</H4><P>The figure above shows the effect of using different carbon sources on the objective flux. We can see, theoretically, our objective pathway has the same flux with both glucose and fructose, both of which exceeds the others.</P><DIV style="text-align: center; font-size: 15px">Figure 5. Carbon sources analysis. D-Glucose, D-Fructose, D-Xylose, Glycerol, Pyruvate, Acetate.</DIV><H4>Nitrogen sources analysis</H4><P>The figures above (Figure 6-30) show the effects of adding different nitrogen sources on the objective flux. There are many kinds of additional nitrogen sources that can increase ACACT1r flux.</P><DIV style="text-align: center; font-size: 15px">Figure 6. Nitrogen sources analysis. 1,5-Diaminopentane, 2',3'-Cyclic AMP, 2',3'-Cyclic CMP, 2',3'-Cyclic GMP, 2',3'-Cyclic UMP, 2,3-diaminopropionate, meso-2,6-Diaminoheptanedioate, 3'-AMP, 3'-cmp, 3'-GMP.</DIV><DIV style="text-align: center; font-size: 15px">Figure 7. 3'-UMP, 4-Aminobutanoate, L-alanine-D-glutamate, L-alanine-D-glutamate-meso-2,6-diaminoheptanedioate, L-alanine-D-glutamate-meso-2,6-diaminoheptanedioate-D-alanine, L-alanine-L-glutamate, N-Acetyl-D-galactosamine, N-Acetyl-D-galactosamine 1-phosphate, N-Acetyl-D-glucosamine, N-Acetyl-D-glucosamine 1-phosphate.</DIV><DIV style="text-align: center; font-size: 15px">Figure 8. Nitrogen sources analysis. N-Acetyl-D-mannosamine, N-Acetylmuramate, N-Acetylneuraminate, 4-Amino-4-deoxy-L-arabinose modified core oligosaccharide lipid A, O-Acetyl-L-serine, Adenine, Adenosine, Adenosylcobalamin, Agmatine, beta-Alanine.</DIV><DIV style="text-align: center; font-size: 15px">Figure 9. Nitrogen sources analysis. D-Alanine, L-Alanine, D-Alanyl-D-alanine, Allantoin, AMP, N-Acetyl-D-glucosamine(anhydrous)N-Acetylmuramic acid, aerobactin minus Fe3, Aerobactin, L-Arginine, L-Asparagine.</DIV><DIV style="text-align: center; font-size: 15px">Figure 10. Nitrogen sources analysis. L-Aspartate, Biotin, Cobinamide, Cob(I)alamin, Cys-Gly, Choline, N,N'-diacetylchitobiose, Chloramphenicol, CMP, core oligosaccharide lipid A.</DIV><DIV style="text-align: center; font-size: 15px">Figure 11. Nitrogen sources analysis. core oligosaccharide lipid A diphosphate, coprogen, coprogen unloaded (no Fe(III)), L-Carnitine, D-Carnitine, Cytosine, Hydrogen cyanide, Cyanate, D-Cysteine, L-Cysteine.</DIV><DIV style="text-align: center; font-size: 15px">Figure 12. Nitrogen sources analysis. Cytidine, Deoxyadenosine, dAMP, dCMP, Deoxycytidine, dGMP, Deoxyguanosine, dIMP, Deoxyinosine, Dopamine.</DIV><DIV style="text-align: center; font-size: 15px">Figure 13. Nitrogen sources analysis. doxorubicin, dTMP, dUMP, Deoxyuridine, (enterobacterial common antigen)x4 core oligosaccharide lipid A, phosphoethanolamine KDO(2)-lipid (A), Enterochelin, Ethanolamine, ferric 2,3-dihydroxybenzoylserine, Fe(III)hydroxamate.</DIV><DIV style="text-align: center; font-size: 15px">Figure 14. Nitrogen sources analysis. Fe(III)hydoxamate, Ferrichrome, Ferrichrome minus Fe(III), Fe-enterobactin, ferroxamine, ferroxamine minus Fe(3), fructoselysine, sn-Glycero-3-phosphocholine, sn-Glycero-3-phosphoethanolamine, Glycerophosphoserine.</DIV><DIV style="text-align: center; font-size: 15px">Figure 15. Nitrogen sources analysis. D-Glucosamine, D-Glucosamine 6-phosphate, gamma-butyrobetaine, GDP, L-Glutamine, L-Glutamate, Glycine, Glycine betaine, GMP, Guanosine.</DIV><DIV style="text-align: center; font-size: 15px">Figure 16. Nitrogen sources analysis. Oxidized glutathione, Reduced glutathione, GTP, Guanine, hepta-acylated core oligosaccharide lipid A (E. coli), hepta-acylated KDO(2)-lipid (A), L-Histidine, L-Homoserine, Hypoxanthine, L-Isoleucine.</DIV><DIV style="text-align: center; font-size: 15px">Figure 17. Nitrogen sources analysis. IMP, Indole, Inosine, KDO(2)-lipid IV(A), L-Leucine, KDO(2)-lipid (A), cold adapted KDO(2)-lipid (A), L-Lysine, D-Methionine, L-Methionine.</DIV><DIV style="text-align: center; font-size: 15px">Figure 18. Nitrogen sources analysis. L-methionine-R-sulfoxide, L-Methionine Sulfoxide, minocycline, S-Methyl-L-methionine, Nitrous oxide, Nicotinate, Ammonium, NMN, Nitric oxide, Nitrite.</DIV><DIV style="text-align: center; font-size: 15px">Figure 19. Nitrogen sources analysis. Nitrate, novobiocin, (O16 antigen)x4 core oligosaccharide lipid A, Ornithine, Orotate, Phenethylamine, L-Phenylalanine, Protoheme, (R)-Pantothenate, L-Proline.</DIV><DIV style="text-align: center; font-size: 15px">Figure 20. Nitrogen sources analysis. L-Prolinylglycine, psicoselysine, O-Phospho-L-serine, Putrescine, Pyridoxamine, Pyridoxal, Pyridoxine, rifampin, D-Serine, L-Serine.</DIV><DIV style="text-align: center; font-size: 15px">Figure 21. Nitrogen sources analysis. Spermidine, Taurine, Thiocyanate, Thiamin, L-Threonine, L-Threonine O-3-phosphate, Thymine, Thymidine, trimethylamine, Trimethylamine N-oxide.</DIV><DIV style="text-align: center; font-size: 15px">Figure 22. Nitrogen sources analysis. L-Tryptophan, tetracycline, Tyramine, L-Tyrosine, Phosphotyrosine, UDP-N-acetyl-D-glucosamine, UDP-N-acetyl-D-galactosamine, UDPglucose, UDPgalactose, UDP-D-glucuronate.</DIV><DIV style="text-align: center; font-size: 15px">Figure 23. Nitrogen sources analysis. UMP, Uracil, Urea, Uridine, L-Valine, Xanthine, Xanthosine 5'-phosphate, Xanthosine.</DIV><H4>Phosphorus sources analysis</H4><P>The figures above show the effect of using different phosphorus sources on the objective flux. We can see that our objective flux is not sensitive to the additional phosphorus sources.</P><DIV style="text-align: center; font-size: 15px">Figure 24. Phosphorus sources analysis. 2',3'-Cyclic AMP, 2',3'-Cyclic CMP, 2',3'-Cyclic GMP, 2',3'-Cyclic UMP, 3'-AMP, 3'-cmp, 3'-GMP, 3'-UMP, N-Acetyl-D-galactosamine 1-phosphate, N-Acetyl-D-glucosamine 1-phosphate.</DIV><DIV style="text-align: center; font-size: 15px">Figure 25. Phosphorus sources analysis. 4-Amino-4-deoxy-L-arabinose modified core oligosaccharide lipid A, Adenosylcobalamin, AMP, Cob(I)alamin, CMP, core oligosaccharide lipid A, core oligosaccharide lipid A diphosphate, dAMP, dCMP, dGMP.</DIV><DIV style="text-align: center; font-size: 15px">Figure 26. Phosphorus sources analysis. dIMP, dTMP, dUMP, (enterobacterial common antigen)x4 core oligosaccharide lipid A, phosphoethanolamine KDO(2)-lipid (A), D-Fructose 6-phosphate, D-Glucose 1-phosphate, sn-Glycero-3-phosphocholine, sn-Glycero-3-phosphoethanolamine, Glycerophosphoglycerol.</DIV><DIV style="text-align: center; font-size: 15px">Figure 27. Phosphorus sources analysis. sn-Glycero-3-phospho-1-inositol, Glycerophosphoserine, D-Glucose 6-phosphate, alpha-D-Galactose 1-phosphate, D-Glucosamine 6-phosphate, GDP, D-Glucuronate 1-phosphate, Glycerol 2-phosphate, Glycerol 3-phosphate, GMP.</DIV><DIV style="text-align: center; font-size: 15px">Figure 28. Phosphorus sources analysis. GTP, hepta-acylated core oligosaccharide lipid A (E. coli), hepta-acylated KDO(2)-lipid (A), IMP, KDO(2)-lipid IV(A), KDO(2)-lipid (A), cold adapted KDO(2)-lipid (A), D-Mannose 6-phosphate, myo-Inositol hexakisphosphate, NMN.</DIV><DIV style="text-align: center; font-size: 15px">Figure 29. Phosphorus sources analysis. (O16 antigen)x4 core oligosaccharide lipid A, Phosphate, Phosphonate, O-Phospho-L-serine, alpha-D-Ribose 5-phosphate, L-Threonine O-3-phosphate, Phosphotyrosine, UDP-N-acetyl-D-glucosamine, UDP-N-acetyl-D-galactosamine, UDPglucose.</DIV><DIV style="text-align: center; font-size: 15px">Figure 30. Phosphorus sources analysis. UDPgalactose, UDP-D-glucuronate, UMP, Xanthosine 5'-phosphate.</DIV><H4>Sulfur sources analysis</H4><P>The figures above (Figure 31-33) show the effects of adding different sulfur sources on the objective flux. We can see that our objective flux is not sensitive to the additional sulfur sources except reduced glutathione, which can be also regarded as nitrogen source.</P><DIV style="text-align: center; font-size: 15px">Figure 31. Sulfur sources analysis. 5-Methylthio-D-ribose, Biotin, butanesulfonate, Cys-Gly, D-Cysteine, L-Cysteine, Dimethyl sulfide, Dimethyl sulfoxide, ethanesulfonate, Oxidized glutathione.</DIV><DIV style="text-align: center; font-size: 15px">Figure 32. Sulfur sources analysis. Reduced glutathione, Hydrogen sulfide, Isethionic acid, Lipoate, D-Methionine, L-Methionine, L-methionine-R-sulfoxide, L-Methionine Sulfoxide, S-Methyl-L-methionine, methanesulfonate.</DIV><DIV style="text-align: center; font-size: 15px">Figure 33.  Sulfur sources analysis. sulfur dioxide, Sulfite, Sulfate, sulfoacetate, Taurine, Thiocyanate, Thiamin, Thiosulfate.</DIV><H4>Ions analysis</H4><P>The figures above (Figure 34-35) show the effects of adding different ions on the objective flux. We can see that our objective flux is not sensitive to the additional ions.</P><DIV style="text-align: center; font-size: 15px">Figure 34. Ions analysis. Cu+, silver, Cu2+, magnesium, Co2+, Mn2+, Sodium, nickel, Zinc, Calcium.</DIV><DIV style="text-align: center; font-size: 15px">Figure 35. Ions analysis. Cadmium, Chloride, Fe2+, Fe3+.</DIV><H4>Amino acids analysis</H4><P>The figures above (Figure 36-38) show the effects of adding different amino acids on the objective flux. These amino acids can be also regarded as nitrogen sources. There are many kinds of additional amino acids that can increase ACACT1r flux. It is worth mentioning that the addition of L-serine could reduce our objective flux.</P><DIV style="text-align: center; font-size: 15px">Figure 36. Amino acids analysis. L-Tryptophan, L-Alanine, D-Alanine, beta-Alanine, Glycine, L-Arginine, L-Asparagine, L-Aspartate, D-Cysteine, L-Cysteine.</DIV><DIV style="text-align: center; font-size: 15px">Figure 37. Amino acids analysis.L-Glutamine, L-Glutamate, L-Histidine, L-Isoleucine, L-Leucine, L-Lysine, D-Methionine, L-Methionine, L-Phenylalanine, L-Proline.</DIV><DIV style="text-align: center; font-size: 15px">Figure 38. Amino acids analysis. D-Serine, L-Serine, L-Threonine, L-Tryptophan, L-Tyrosine, L-Valine.</DIV><P>In summary, the predictive results suggest that our objective pathway - ACACT1r is not sensitive to most of the phosphorus sources, sulfur sources and ions, while many nitrogen-related sources can increase our objective flux. In practical production, we should focus on selecting appropriate nitrogen sources.</P><DIV><A href="https://static.igem.org/mediawiki/2018/a/ac/T--SDU-CHINA--code.zip">DOWNLOAD OUR CODES</A></DIV><H4 id="main-title">References</H4><P>[1] Gianchandani, Erwin P., A. K. Chavali, and J. A. Papin. &quot;The application of flux balance analysis in systems biology.&quot; Wiley Interdisciplinary Reviews Systems Biology &amp; Medicine 2.3(2010):372-382.
[2] Heshiki, Yoshitaro, &quot;Optimization of Polyhydroxybutyrate Production in Recombinant Escherichia Coli Through Metabolic Modeling and Simulation&quot; (2013). All Graduate Plan B and other Reports. 291.
[3] Ebrahim, Ali, et al. &quot;COBRApy: COnstraints-Based Reconstruction and Analysis for Python.&quot; Bmc Systems Biology 7.1(2013):1-6.</P></DIV></DIV><DIV id="footer"><DIV id="contact"><DIV><A href="mailto:sdubioigem@163.com">mailto:sdubioigem@163.com</A></DIV><DIV><A href="https://www.instagram.com/sdubiochina_2018/">www.instagram.com/sdubiochina_2018/</A></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>